Cargando…

The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity

SIMPLE SUMMARY: The Hepatocellular Carcinoma (HCC) remains a major concern for the public health. The pandemic of metabolic syndrome in the Western societies and the considerable amounts of viral hepatitis in the underdeveloped countries keep fueling s the development of HCC. The hepatotropic viruse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadakos, Stavros P., Dedes, Nikolaos, Kouroumalis, Elias, Theocharis, Stamatios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264914/ https://www.ncbi.nlm.nih.gov/pubmed/35804922 http://dx.doi.org/10.3390/cancers14133150

Ejemplares similares

The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
por: Papadakos, Stavros P., et al.
Publicado: (2022)

The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Role of NLRP3 inflammasome activation in HCC cell progression
por: Dai, Bingling, et al.
Publicado: (2023)

Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation
por: Papadakos, Stavros P., et al.
Publicado: (2023)

NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis
por: Ciążyńska, Magdalena, et al.
Publicado: (2020)

Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the Lung
por: Chenery, Alistair L., et al.
Publicado: (2019)

Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches
por: Arvanitakis, Konstantinos, et al.
Publicado: (2023)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages
por: Zeng, Qiong-zhen, et al.
Publicado: (2019)

NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
por: Zhang, Yiwen, et al.
Publicado: (2021)

The EPH/Ephrin System in Colorectal Cancer
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Suppression of Ribosomal Function Triggers Innate Immune Signaling through Activation of the NLRP3 Inflammasome
por: Vyleta, Meghan L., et al.
Publicado: (2012)

TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles)
por: Xing, Y, et al.
Publicado: (2016)

From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus
por: Nițulescu, Iris Maria, et al.
Publicado: (2023)

E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells
por: Wei, Qing, et al.
Publicado: (2019)

Inflammasomes and Their Role in Innate Immunity of Sexually Transmitted Infections
por: Verma, Vivek, et al.
Publicado: (2016)

Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets
por: Stergiou, Ioanna E., et al.
Publicado: (2023)

Adjuvants of Immunity : Harnessing Innate Immunity to Promote Adaptive Immunity
por: Bendelac, Albert, et al.
Publicado: (2002)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

Role of the NLRP3 inflammasome in cancer
por: Moossavi, Maryam, et al.
Publicado: (2018)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Role of the NLRP3 Inflammasome in Preeclampsia
por: Shirasuna, Koumei, et al.
Publicado: (2020)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages
por: Lee, Po-Yen, et al.
Publicado: (2021)

Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics
por: Papadakos, Stavros P., et al.
Publicado: (2023)

NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma
por: Huang, Cong-Fa, et al.
Publicado: (2017)

The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia
por: Pergaris, Alexandros, et al.
Publicado: (2023)

Role of the Nlrp3 Inflammasome in Microbial Infection
por: Anand, Paras K., et al.
Publicado: (2011)

Focus on the Role of NLRP3 Inflammasome in Diseases
por: Fusco, Roberta, et al.
Publicado: (2020)

The Role of NLRP3 Inflammasome in Pneumococcal Infections
por: Surabhi, Surabhi, et al.
Publicado: (2020)

The Role of NLRP3 Inflammasome in Lupus Nephritis
por: Oliveira, Camila Barbosa, et al.
Publicado: (2021)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis
por: Yin, Hui, et al.
Publicado: (2022)

Role of NLRP3 inflammasome in systemic sclerosis
por: Lin, Cong, et al.
Publicado: (2022)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uld34hrameuh4kf8rg1shi2ars